Lv2
110 积分 2024-08-26 加入
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials
9小时前
已完结
Use of letrozole after aromatase inhibitor-based therapy (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled phase 3 trial
5个月前
已完结
Prognostic significance of SASP-related gene signature of radiation therapy in head and neck squamous cell carcinoma
8个月前
已完结
皖公网安备34019202002308
